Morishita JintanMORISHITA JINTAN CO.,LTD.4524東証スタンダード医薬品FY ending Mar 2026, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|---|
| Healthcare business division | — | 7,1632.6% | 8,391-1.8% | 8,349-5.5% | — | — |
| Capsule contract manufacturing business division | — | 2,3954.5% | 2,96224.1% | 4,04928.7% | — | — |
| Other | 0.0%5y | 366.7% | 5100.0% | 9100.0% | 7100.0% | 7-100.0% |
| Consumer business division | -6.9%2y | — | — | 5,4503.3% | 4,787-1.2% | 4,724-2.1% |
| Solution business division | +7.0%2y | — | — | 6,9467.5% | 7,97110.7% | 7,95610.0% |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書－第89期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第88期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第87期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第86期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第85期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第84期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 48 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.